163 related articles for article (PubMed ID: 32236622)
1. The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.
Kim JS; Jeong SK; Oh SJ; Lee CG; Kang YR; Jo WS; Jeong MH
Int J Oncol; 2020 Jun; 56(6):1405-1416. PubMed ID: 32236622
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice.
Jeong MH; Yang KM; Choi YJ; Kim SD; Yoo YH; Seo SY; Lee SH; Ryu SR; Lee CM; Suh Hs; Jo WS
Int Immunopharmacol; 2012 Nov; 14(3):328-33. PubMed ID: 22884509
[TBL] [Abstract][Full Text] [Related]
3. The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
Choi YJ; Heo K; Park HS; Yang KM; Jeong MH
Int J Oncol; 2016 Oct; 49(4):1479-88. PubMed ID: 27498957
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic inhibition of AKT leads to cell death in relapsed multiple myeloma.
Song IS; Jeong YJ; Jeong SH; Kim HK; Ha NC; Shin M; Ko KS; Rhee BD; Shim S; Jang SW; Han J
Cancer Lett; 2018 Sep; 432():205-215. PubMed ID: 29933047
[TBL] [Abstract][Full Text] [Related]
5. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
Kim DH; Sung B; Kim JA; Kang YJ; Hwang SY; Hwang NL; Suh H; Choi YH; Im E; Chung HY; Kim ND
Int J Oncol; 2017 Aug; 51(2):715-723. PubMed ID: 28656256
[TBL] [Abstract][Full Text] [Related]
6. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
8. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
Knutson KL; Dang Y; Lu H; Lukas J; Almand B; Gad E; Azeke E; Disis ML
J Immunol; 2006 Jul; 177(1):84-91. PubMed ID: 16785502
[TBL] [Abstract][Full Text] [Related]
9. Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells.
Jeong MH; Yang KM; Jeong DH; Lee CG; Oh SJ; Jeong SK; Lee KW; Jo YR; Jo WS
J Radiat Res; 2014 May; 55(3):464-75. PubMed ID: 24403520
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
Mason K; Staab A; Hunter N; McBride W; Petersen S; Terry N; Milas L
Int J Oncol; 2001 Mar; 18(3):599-606. PubMed ID: 11179493
[TBL] [Abstract][Full Text] [Related]
11. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
Jarnicki AG; Lysaght J; Todryk S; Mills KH
J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
[TBL] [Abstract][Full Text] [Related]
12. A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.
Jeong SH; Jo WS; Song S; Suh H; Seol SY; Leem SH; Kwon TK; Yoo YH
Biochem Pharmacol; 2009 Apr; 77(8):1337-47. PubMed ID: 19426672
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells.
Choi YJ; Yang KM; Kim SD; Yoo YH; Lee SW; Seo SY; Suh H; Yee ST; Jeong MH; Jo WS
Exp Ther Med; 2012 Apr; 3(4):592-598. PubMed ID: 22969934
[TBL] [Abstract][Full Text] [Related]
14. Tumor-promoting effect of IL-23 in mammary cancer mediated by infiltration of M2 macrophages and neutrophils in tumor microenvironment.
Nie W; Yu T; Sang Y; Gao X
Biochem Biophys Res Commun; 2017 Jan; 482(4):1400-1406. PubMed ID: 27956175
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages.
Jeong SK; Yang K; Park YS; Choi YJ; Oh SJ; Lee CW; Lee KY; Jeong MH; Jo WS
Int Immunopharmacol; 2014 Oct; 22(2):303-10. PubMed ID: 25042796
[TBL] [Abstract][Full Text] [Related]
16. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
17. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol exerts antitumor effects by downregulating CD8
Zhang Q; Huang H; Zheng F; Liu H; Qiu F; Chen Y; Liang CL; Dai Z
Oncoimmunology; 2020 Oct; 9(1):1829346. PubMed ID: 33150044
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
Yang Y; Paik JH; Cho D; Cho JA; Kim CW
Int Immunopharmacol; 2008 Apr; 8(4):542-7. PubMed ID: 18328445
[TBL] [Abstract][Full Text] [Related]
20. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
